A expedient choice in the treatment of acute upper respiratory tract infections in childhood
DOI:
https://doi.org/10.15574/SP.2025.5(149).713Keywords:
acute tonsillopharyngitis, children, treatment, Coldisept nanoSilver throat sprayAbstract
Acute tonsillopharyngitis is one of the main reasons for prescribing antibiotics to children. Inappropriate use of antibiotics in children often leads to the development of antibioticresistance.
Aim - to investigate the effectiveness and safety of the use "Coldysept nanoSilver throat spray" compared to standard therapy to optimize the treatment of acute tonsillopharyngitis in children.
Materials and methods. 80 patients aged 6 to 17 years with signs of acute respiratory infection of the upper respiratory tract were observed and divided into two groups. The main group consisted of 50 patients who received standard therapy with "Coldysept nanoSilver throat spray" for 7 days, the comparison group consisted of 30 patients who received standard therapy according to guidelines.
Results. The effectiveness of the "Coldysept nanoSilver throat spray" use in the therapy of children on the 3rd day was associated with a significantly better reduction of sore throat, difficulty swallowing and plaque on the tonsils. The frequency registration of the minimum score of acute process symptoms severity on the 5th day treatment demonstrates a similar prevalence of them in main group. On the 7th day of therapy, these symptoms were not observed in patients in the main group, while in children in the control group the symptoms persisted.
Conclusions. The obtained data of the dynamic comparative analysis of the use of “Coldisept nanoSilver throat spray” in the complex treatment of children with acute upper respiratory tract infections compared to standard tactics confirm that the proposed approach significantly accelerates recovery with good tolerability and safety of use.
The research was carried out in accordance with the principles of the Declaration of Helsinki. Informed consent of the child and child's parents was obtained for the researches.
No conflict of interest was declared by the author.
References
Ather B, Mirza TM, Edemekong PF. (2023). Airborne Precautions. Mar 13. In: Stat Pearls [Internet]. Treasure Island (FL): Stat Pearls Publishing; 2025 Jan.
Barbieri E, Donà D, Cantarutti A, Lundin R, Scamarcia A, Corrao G et al. (2019). Antibiotic prescriptions in acute otitis media and pharyngitis in Italian pediatric out patients. Ital J Pediatr. 45(1):103. https://doi.org/10.1186/s13052-019-0696-9; PMid:31420054 PMCid:PMC6697973
Ebell MH, Smith MA, Barry HC, Ives K, Carey M. (2000). The rational clinical examination. Does this patient have strep throat? JAMA. 13; 284(22): 2912-2918. https://doi.org/10.1001/jama.284.22.2912; PMid:11147989
ESCMID Sore Throat Guideline Group; Pelucchi C, Grigoryan L, Galeone C, Esposito S, Huovinen P et al. (2012). Guideline for the management of acute sore throat. ClinMicrobiolInfect. Suppl 1: 1-28. https://doi.org/10.1111/j.1469-0691.2012.03766.x; PMid:22432746
Kosakovskyi AL, Holovnya OM, Gunko SG, Kosakivska IA, Sinyachenko VV. (2024). Determination of the antimicrobial action of «Coldisept nanoSilver nasal spray» and «Coldisept nanoSilver throat spray». Modern Pediatrics. Ukraine. 5(141): 11-15. https://doi.org/10.15574/SP.2024.5(141).1115
Liang K, Liu Y, Jiang F. (2024). Analysis of therapeutic effect of silver-based dres sings on chronic wound healing. IntWound J. 21(8): e70006. https://doi.org/10.1111/iwj.70006; PMid:39087750 PMCid:PMC11292664
Mathur P, Jha S, Ramteke S, Jain NK. (2018). Pharmaceutical aspects of silver nano particles. Artif Cells Nanomed Biotechnol. 46; Suppl 1: 115-126. https://doi.org/10.1080/21691401.2017.1414825; PMid:29231755
MOZ Ukrainy. (2022). Metodychni rekomendatsii shchodo znebolennia postrazhdalykh na etapakh evakuatsii. Nakaz Ministerstva okhorony zdoroviaUkrainy 28 chervnia 2022 roku No. 1122.
Palm J, Fuchs K, Stammer H, Schumacher-Stimpfl A, Milde J. (2018) Efficacy and safety of a triple active sore thro at lozenge in the treatment of patients with аcute pharyngitis: Results of a multi-centre, randomised, placebo-controlled, double-blind, parallel-grouptrial (DoriPha). Int J ClinPract. 72(12): e13272. https://doi.org/10.1111/ijcp.13272; PMid:30329199 PMCid:PMC6282512
Pankhurst CL. (2013). Candidiasis (oropharyngeal). BMJ ClinEvid. 8; 2013: 1304.
Pellegrino R, Timitilli E, Verga MC, Guarino A, Iacono ID, Scotese I et al. (2023). Other members of the Italian Panel for the Management of Acute Pharyngitis in Children. Acute pharyngitis in children and adults: descriptive comparison of current recommendations from national and international guidelines and future perspectives. Eur J Pediatr. 182(12): 5259-5273. https://doi.org/10.1007/s00431-023-05211-w; PMid:37819417 PMCid:PMC10746578
Pugach P, Sadeghi-Latefi N. (2024). Supporting respiratory epithelia and lowering inflammation to effectively treat common cold symptoms: A randomized controlled trial. PLoSOne. 27; 19(11): e0301959. https://doi.org/10.1371/journal.pone.0301959; PMid:39602479 PMCid:PMC11602100
Shulman ST, Bisno AL, Clegg HW, Gerber MA, Kaplan EL, Lee G et al. (2012) Infectious Diseases Society of America. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin Infect Dis. Nov 15; 55(10): e86-102. https://doi.org/10.1093/cid/cis629; PMid:22965026 PMCid:PMC7108032
Sykes EA, Wu V, Beyea MM, Simpson MTW, Beyea JA. (2020). Pharyngitis: Approach to diagnosis and treatment. Can Fam Physician. 66(4): 251-257.
Thai TN, Dale AP, Ebell MH. (2018). Signs and symptoms of Group A versus Non-Group A strep throat: A meta-analysis. Fam Pract. 23; 35(3): 231-238. https://doi.org/10.1093/fampra/cmx072; PMid:29045629
Vishwanath N, Whitaker C, Allu S, Clippert D, Jouffroy E, Hong J et al. (2022). Silver as an Antibiotic-Independent Antimicrobial: Review of Current Formulations and Clinical Relevance. SurgInfect (Larchmt). 23(9): 769-780. https://doi.org/10.1089/sur.2022.229; PMid:36178480
Wächtler H, Kaduszkiewicz H, Kuhnert O, Malottki KA, Maaß S, Hedderich J et al. (2023). Influence of a guideline or an additional rapid strep test on antibiotic prescriptions for sore throat: the cluster randomized controlled trial of HALS (Halsund Antibiotika Leitlinien Strategien). BMC PrimCare. 20; 24(1): 75. https://doi.org/10.1186/s12875-023-01987-w; PMid:36941540 PMCid:PMC10029262
Yoon YK, Park CS, Kim JW, Hwang K, Lee SY, Kim TH et al. (2017). Guidelines for the Antibiotic Use in Adults with Acute Upper Respiratory Tract Infections. Infect Chemother. 49(4): 326-352. https://doi.org/10.3947/ic.2017.49.4.326; PMid:29299900 PMCid:PMC5754344
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Modern pediatrics. Ukraine
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The policy of the Journal “MODERN PEDIATRICS. UKRAINE” is compatible with the vast majority of funders' of open access and self-archiving policies. The journal provides immediate open access route being convinced that everyone – not only scientists - can benefit from research results, and publishes articles exclusively under open access distribution, with a Creative Commons Attribution-Noncommercial 4.0 international license (СС BY-NC).
Authors transfer the copyright to the Journal “MODERN PEDIATRICS. UKRAINE” when the manuscript is accepted for publication. Authors declare that this manuscript has not been published nor is under simultaneous consideration for publication elsewhere. After publication, the articles become freely available on-line to the public.
Readers have the right to use, distribute, and reproduce articles in any medium, provided the articles and the journal are properly cited.
The use of published materials for commercial purposes is strongly prohibited.
